Salarius Pharmaceuticals Inc

XNAS:SLRX

4.11

-0.14 (-3.29%)

7:45:27 PM EDT: $4.10 -0.01 (-0.24%)

Salarius Pharmaceuticals Inc Stock, XNAS:SLRX

2450 Holcombe Boulevard, Suite X, Houston, Texas 77021

United States of America

Phone: +1.832.834.6992

Number of Employees: 2

http://salariuspharma.com

Description

Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.